Work

HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues

Year: 2016

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-16-0475

Authors: Xiaoyu Lin, Xiaoli Huang, Tamar Uziel, Paul Hessler, Daniel H. Albert, Lisa A. Roberts-Rapp, Keith F. McDaniel, Warren M. Kati, Yu Shen

Institution: AbbVie (United States)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

OpenAlex ID: W2558696992

FWCI: 3.458

Cites: 42

Cited by: 57

Related to: 10